| Sr. No. | Name Of Product | CAS No. |
| 1 | Abiraterone acetate USP | 154229-18-2 |
| 2 | Febuxostat IH | 144060-53-7 |
| 3 | Enoxaparin Sodium IP/BP/EP/USP | 679809-58-6 |
| 4 | Prilocaine IP/BP/EP/USP | 721-50-6 |
| 5 | Tigecycline USP | 220620-09-7 |
| 6 | Tiapride Hydrochloride BP | 51012-33-0 |
| 7 | Palonosetron Hydrochloride USP | 135729-62-3 |
| 8 | Colistimethate Sodium BP/EP/IP/USP | 8068-28-8 |
| Sr. No. | Name of Product | CAS No. | Application | |
| 1 | Ethyl 2-(4-hydroxyphenyl)-4- m ethylthiazole-5-carboxylate | 161797-99-5 | Febuxostate intermediate | |
| 2 | Ethyl 2-(3-formyl-4-hydroxy phenyl)-4-methylthiazole-5- carboxylate | 161798-01-2 | Febuxostate intermediate | |
| 3 | Ethyl 2-(3-cyano-4-isobutoxy phenyl)-4- methylthiazole-5- carboxylate | 160844-75-7 | Febuxostate intermediate | |
| 4 | MOC-L-tert- Leucine | 162537-11-3 | Atazanavir intermediate | |
| 5 | BOC-L-tert- Leucine | 62965-35-9 | Boceprevir intermediate | |
| 6 | 3,4-(Methylenedioxy)phenol | 533-31-3 | Peroxetine intermediate | |
| 7 | 2,3-Dichloro benzoyl cyanide | 77668-42-9 | Lamotrigine intermediate | |
| 8 | 4-Iodo-1H pyrazole | 3469-69-0 | Crizotinib intermediate | |
| 9 | 4-Chloro-2,6—dimethyl- 3nitropyridone | 15513-48-1 | Grapiprant Intermediate | |
| 10 | 4,5-Dichloro Phenylene Diamine | 5348-42-5 | Maribavir Intermediate |
| Advance API intermediate | |||
| 1 | (R)-dihydro-4-propylfuran-2(3H)-one | 63095-51-2 | Brivaracetam |
| 2 | 1,4-Bis(bromomethyl)benzene | 623-24-5 | Plerixafor |
| 3 | Ethyl-2,4-Dichloropyrimidinecarboxylate | 51940-64-8 | Antineoplastic derivative (Rosuvastatin analogue) |
| 4 | Pyrrolo[2,3-d]pyrimidin-4-ol | 3680-71-5 | Tofacitinib/Baricitinib/ Ruxolitinib |
| 5 | (S)-4-Hydroxy-2-(3-methoxypropyl)- 3,4-dihydro-2H-thieno[3,2-e][1,2]- thiazine -6-sulfonamide-1,1-dioxide | 154127-42-1 | Brinzolamide |
| 6 | Ethyl 2-(2,3-dichloro-6- nitrobenzylamino)acetate hydrochloride | 70380-50-6 | Anagrelide |
| 7 | 2-((1H-Pyrrolo[2,3-b]pyridin-5- yl)oxy)-4-(4-((4′-chloro-5,5- dimethyl3,4,5,6 -tetrahydro- [1,1 ‘- biphenyl]-2-yl)methyl)piperazin-1- yl)benzoic acid | NA | Venetoclax intermediate |
| 8 | 4-(4-aminophenyl)morpholin-3-one | 438056-69-0 | Rivaroxaban |
| 9 | 2-Hydroxybenzene-1,3,5- tricarbaldehyde | 81502-74-1 | Material chemistry – Fluorogenicprobe synthesis |
| 10 | pyridine-3-sulfonyl chloride | 16133-25-8 | Vonoprazan intermediate |
| 11 | 6-chlorohexan-2-one | 10226-30-9 | Pentoxyfyline |
| 12 | yclopropylmethoxy)-4- (difluoromethoxy)benzaldehyde | 151103-09-2 | Roflumilast |
| 13 | 2,5-bis(2,2,2-trifluoroethoxy) benzoicacid | 35480-52-5 | Flacanide |
| 14 | 2,6-bis(chloromethyl)pyridine | 3099-28-3 | |
| 15 | 1-(3,5-dichlorophenyl)-2,2,2- trifluoroethanone | 130336-16-2 | Fluralaner intermediate |
| 16 | 1-(3,4,5-trichlorophenyl)-2,2,2- trifluoroethanone | 158401-00-4 | Lotilaner intermediate |
| 17 | 1-(3,5-dichloro-4-fluorophenyl)- 2,2,2-trifluoroethanone | 1190865-44-1 | Sarolaner intermediate |
| 18 | 1-(3-chloro-5 (trifluoromethyl)phenyl)2,2,2- trifluoro ethanone | 1125812-58-9 | Afoxolaner intermediate |
| 19 | (S)-dec-1-yn-5-ol | 848609-05-2 | Treprostinil Intermediate |
| 20 | 5-(2-fluorophenyl)-1H-pyrrole-3- carbaldehyde | 881674-56-2 | vonoprazan Internediate |
| 21 | 4-(2-amino-2-methylpropyl)phenol | 51706-55-9 | Lubabegron Intermediate |
| 22 | 5-bromo-2-chloro-4’- Ethoxydiphenyl methane | 461432-23-5 | dapagliflozin Intermediate |
| 23 | (S)-methyl 2-(2,6 dichlorobenzamido)-3- (4-nitrophenyl) propanoate | – | Carotegrast Methyl Intermediate |
| 24 | Benzimidine Hydrochloride | 1670-14-0 | fenclorim Intermediate |
| 25 | ((1r,4r)-4- (methylamino)cyclohexyl) methanesulfonic acid | 2124221-12-9 | Oclacitinib maleate Intermediate |
| Custom synthesis | |||
| 26 | 2,2,2-Trifluoro-1-(4- (trifluoromethyl)phenyl)etanone | 74853-66-0 | Custom synthesis |
| 27 | 2,2,2-trifluoro-N- (hydroxymethyl)acetamide | 50667-69-1 | Custom synthesis |
| 28 | (S)-2-Chloropropanoic Acid | 29617-66-1 | Custom synthesis |
| 29 | (R)-(+)-2-(Benzyloxy)propanoic Acid | 100836-85-9 | Custom synthesis |
| 30 | 2-Methylthiazol-5-amine dihydrochloride | NA | Custom synthesis |
| 31 | 3-Thietan-1-ol | 10304-16-2 | Custom synthesis |
| 32 | N-Benzylglycine ethyl ester | 6436-90-4 | Custom synthesis |
| 33 | 3,4,5-Trichloro-1-bromobenzene | 21928-51-8 | Custom synthesis |
| 34 | 3,5-Dichloro-1-bromobenzene | 19752-55-7 | Fluralaner |
| 35 | 4-bromo-2,6-dichloroaniline | 697-88-1 | Custom synthesis |
| 36 | 2-Methylthiophenylboronic acid | 168618-42-6 | Custom synthesis |
| 37 | 2-Bromoindene | 10485-09-03 | Custom synthesis |
| 38 | 2-isopropyl-5-methylhexanal | 66656-67-5 | Custom synthesis |
| 39 | 2-(isobutylthio)phenol | 29549-65-3 | Custom synthesis |
| 40 | 2-Bromothioanisole | 19614-16-5 | Custom synthesis |
| 41 | 3-Oxocyclobutane-1-carboxylic acid | 23761-23-1 | Custom synthesis |
| 42 | 2,3-Diamino-5-bromopyridine | 38875-53-5 | Custom synthesis |
| 43 | 2,3-Diaminopyridine | 452-58-4 | Custom synthesis |
| 44 | 6-Bromo-2-methyl-4H-chromen-4-one | NA | Custom synthesis |
| 45 | 6-Bromo-2-ethyl-4H-chromen-4-one | NA | Custom synthesis |
| 46 | 3,4-Dimethoxycinnamic acid | 14737-89-4 | Custom synthesis |
| 47 | 3-Bromobenzaldehyde | 3132-99-8 | Custom synthesis |
| 48 | 3-(Difluoromethoxy)aniline | 22236-08-04 | Custom synthesis |
| 49 | 4-Chloro-2-Fluoroaniline | 57946-56-2 | Custom synthesis |
| 50 | Ethyl-6-Bromo-2,2-Dimethylhexanoate | 78712-62-6 | Custom synthesis |
| 51 | Ethyl-4-Chloro-3-hydroxy-5- nitrobenzoate | – | Custom synthesis |
| 52 | Tert.butyl-4-Chloro-3-hydroxy-5- nitrobenzoate | – | Custom synthesis |
| 53 | (E)-but-2-ene-1,4-diamine dihydrochloride | – | Custom synthesis |
| 54 | 1-Bromo-3-chloro-5- (trifluoromethyl)benzene | 928783-85-1 | Custom synthesis |
| 55 | 3-Chloro-5-(trifluoromethyl)aniline | 69411-05-08 | Custom synthesis |
| 56 | 3-Nitro-2-methyl aniline | 603-83-8 | Custom synthesis |
| 57 | 5-Bromo-3-Nitro-2-methylaniline | Not available | Custom synthesis |
| 5 8 | 5-Bromo-1-fluoro-2-methyl-3- nitrobenzene | 502496-34-6 | Custom synthesis |
| 5 9 | 5-Bromo-2-fluorobenzotrifluoride | 393-37-3 | Custom synthesis |
| 6 0 | 1-(difluoromethyl)-4-nitro-1H-pyrazole | 956477-64-8 | Custom synthesis |
| 6 1 | Methyl 4-bromo-3-nitrobenzoate | 2363-16-8 | Custom synthesis |
| 6 2 | 3-Bromophenacyl bromide | 18523-22-3 | Custom synthesis |
| 6 3 | Pyridine-3-sulfonylchloride | 16133-25-8 | Custom synthesis |
| 6 4 | 2,6-Difluorophenol | 28177-48-2 | Custom synthesis |
| 6 5 | 2,6-Difluorobenzaldehyde | 437-81-0 | Custom synthesis |
| 6 6 | (S)-Oxiran-2-ylmethyl 3- nitrobenzenesulfonate | 115314-14-2 | Custom synthesis |
| 6 7 | 2-(2-Thienyl)phenol | 106584-13-8 | Custom synthesis |
| 6 8 | N(5-Fluoropyridin-2-yl)acetamide | 100304-88-9 | Custom synthesis |
| 6 9 | 1,1-Diphenyl acetone | 781-35-1 | Custom synthesis |
| 7 0 | 1,3-Diphenylacetone | 0102-04-05 | Custom synthesis |
| 7 1 | 4-bromo-2-chloro-6- fluorobenzenamine | 885453-49-6 | Custom synthesis |
| 7 2 | 3-butoxyphenylboronic acid | 352534-81-7 | Custom synthesis |
| 7 3 | 3-chlorophyl amine hydrochloride | 6276-54-6 | Custom synthesis |
| 7 4 | 1-(3-aminopropyl)pyrrolidin-2-one | 7663-77-6 | Custom synthesis |
| Product List | ||
| S. no | PRODUCT | TARGETED FORMULATIONS |
| Anti-Obesity | ||
| 1 | Orlistat Pellets (In-house & USP) 50%, (Note: Patent Non-infringing product) | Pellets/Granules (for capsules) |
| Macrolide Antibiotic | ||
| 2 | Clarithromycin Taste masked Micro Pellets, Granules 27.5%, 30%, 33%, 42% & 43% | Micro pellets/Granules (for capsules, Tablets, suspension) |
| 3 | Azithromycin Taste Masked Micro Pellets, Granules 7.5%, 20%, 22% & 40% | Micro pellets/Granules (for capsules, Tablets, suspension) |
| Anti-Fungal | ||
| 4 | Itraconazole Pellets 22%, 40%, 44% | Pellets (for capsules) Solution (Oral Solution) |
| Antiemetic | ||
| 5 | Aprepitant Pellets 40% (Note: Patent Non-infringing product) | Pellets/Micro pellets (for capsules) |
| Alpha Blockers | ||
| 6 | Tamsulosin HCL SR Pellets 0.12%, 0.125%, 0.13%, 0.16% & 0.20% | Pellets/Micro pellets (for capsules) |
| Anti-Depressant | ||
| 7 | Duloxetine HCL EC Pellets 17%, 20%, 22% | Pellets/Micro pellets (for capsules) |
| 8 | Venlafaxine SR Pellets 32%, 33% | Pellets/Micro pellets (for capsules) |
| Anti Ulcerant | ||
| 9 | Dexlansoprazole Pellets 17%, 20%, 22.5%, 23% | Pellets (for capsules) |
| 10 | Esomeprazole Pellets/ Micro/MUPS 8.5%, 10%, 22.5% | Pellets/Micro pellets (for capsules), MUPS (for Tablets) |
| 11 | Lansoprazole Pellets/ Micro Pellets 8.5%, 12.5% | Pellets/Micro pellets (for capsules), MUPS (for Tablets) |
| 12 | Omeprazole Pellets 7.5%, 8.5%, 9.5%, 10.5%, 20%, 22%, 22.5%, 30% | Pellets (for capsules) |
| 13 | Pantoprazole Pellets 8.5%, 15%, MUPS | Pellets (for capsules), MUPS(compressed for Tablets) |
| Anti-Inflammatory | ||
| 14 | Diclofenac Sodium Pellets 30%, 31.25% | Pellets (for capsules) |
| 15 | Mebeverine Pellets 80% | Pellets/Micro Pellets (for capsules) |
| 16 | Mesalamine Pellets, Premix/Granules, 54%, 70%, 90%, 96.38% | Pellets (for capsules), Premix/Granules (for Sachet, Tablets) |
| Immunosuppressant | ||
| 17 | Everolimus Granules 2.68% | Granules (for Tablets) |
| 18 | Sirolimus Micro Pellets 0.13%, 0.3%, 0.6% & 1.2% | Pellets/Micro pellets (for capsules), Granules (for Tablets) |
| 19 | Tacrolimus Pellets/ Micro Pellets 0.5%, 1% & 5% | Pellets/Micro pellets (for capsules) |
| Carbonic Anhydrase Inhibitor | ||
| 20 | Brinzolamide Nano Suspension 1% | Nano particles (for Ophthalmic Suspensions) |
| Oncology | ||
| 21 | Erlotinib MUPS, Granules | MUPS/Granules (for suspension) |
| Mitotic Inhibitor | ||
| 22 | Paclitaxel Lyophilized powder/Vials, Nano particles(Patent Non Infringing) | Nano particles (for Injections) |
| Anticoagulants | ||
| 23 | Dipyridamole Pellets 42.5% | Pellets/Micro pellets (for Capsules) |
| Anti Asthamatic | ||
| 24 | Budesonide Pellets 0.8%, Nano Solution | Solution (For Nano Suspension/Soft Mist), Pellets (for Capsules) |
| Digestant | ||
| 25 | Pancreatin EC Pellets (10,000 Units; 25,000 Units; 40,000 Units) both Porcine and Bovine Native | Pellets (for Capsules) |
| Direct Thrombin Inhibitor’s (DTIs) | ||
| 26 | Dabigatran Pellets 40% | Pellets (for Capsules) |
| Anti Hypertension | ||
| 27 | Nicardipine Pellets 22% | Pellets (for Capsules) |
| NMDA Receptor Antagonist | ||
| 28 | Memantine SR Pellets 10.5% | Pellets (for Capsules) |
| Vasodilator & Antihypertensive agent | ||
| 29 | Vincamine SR Pellets 13% | Pellets (for Capsules) |
| Iron & Vitamin Supplements (Transdermal) | ||
| 30 | Iron and Vitamin Liposomes | Transdermal Oil |
| NOTE: Products protected by ongoing Patents are not offered for commercial supplies | ||
© 2024 Rajbhushan Pharmachem Pvt. Ltd. | All Rights Reserved Designed & Developed by Egniol Services Private Limited.
